News

Pfizer Advances Bold Vision for Future of Cancer Care at the ASCO 2025 Annual Meeting
Pfizer Inc. (NYSE: PFE) will showcase data across its portfolio of potential breakthrough cancer medicines at the 2025 ...
Fierce Pharma2d
Gilead's Trodelvy-Keytruda proposal hits goal in first-line triple-negative breast cancer
In the first phase 3 trial to show the superiority of a TROP2-targeted antibody-drug conjugate and an immunotherapy agent in ...
Pfizer to have two oral presentations featured in ASCO pre-meeting briefing
Pfizer (PFE) will showcase data across its portfolio of potential breakthrough cancer medicines at the 2025 American ...
Screening Saves Lives: Working Together To Promote Early Cancer Detection
Screening tests are critical in early detection because they can find cancer before symptoms appear, when treatment is more ...
Fierce Biotech13d
Pfizer shakes up R&D footprint in San Diego with $255M site sale, 56 layoffs
Pfizer is officially bidding adieu to its sprawling research site in San Diego as it readjusts its local footprint and moves into a new site. | The company is moving its oncology R&D digs in San Diego ...